Talc mesothelioma case in South Carolina ends in mistrial for Johnson & Johnson

Johnson & Johnson faces more than 9,000 talc lawsuits, according to a recent quarterly filing. (Pixabay)

Right on the heels of a legal defeat for Johnson & Johnson in California, a jury in South Carolina has failed to reach a decision in a case alleging the company's talc baby powder can cause mesothelioma.

Jurors in South Carolina couldn't reach a unanimous decision in the case of Bertila Boyd-Bostic, who passed away last year at age 30 from the cancer, according to Reuters. 

Johnson & Johnson representatives said the company is disappointed the jury didn't reach a decision in its favor, while attorneys for the plaintiffs said they intend retry the case as soon as possible, the news service reports.

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

RELATED: Johnson & Johnson suffers another cancer-suit loss as talc case count climbs above 9,000 

The mistrial in South Carolina came the same week a jury in Los Angeles ordered J&J to pay $25.75 million in the mesothelioma case of Joanne Anderson. Before that, a jury in New Jersey awarded a $117 million verdict in a case brought by Stephen Lanzo. J&J prevailed in an earlier Los Angeles case alleging a link.

The drugmaker has been battling claims its storied talcum powder can cause ovarian cancer for years, and plaintiffs have increasingly filed lawsuits alleging a link to mesothelioma. 

Johnson & Johnson has denied its talc contains asbestos based on "multiple independent, non-litigation-driven scientific evaluations." But in various cases, plaintiffs' attorneys have presented old documents showing asbestos appeared in some tests and that J&J employees debated internally about the issue.    

RELATED: Asbestos case against Johnson & Johnson, Imerys climbs to $117M in damages  

In all, J&J faces about 9,100 talc lawsuits as of its last quarterly filing with the Securities and Exchange Commission. In previous ovarian cancer cases, the company has won in New Jersey and St. Louis, and has managed to get verdicts of $417 million and $72 million thrown out on appeal. The company is in the process of appealing ovarian cancer losses of $55 million, $70 million and $110 million.

Suggested Articles

With a slate of vaccine authorizations on the horizon, vaccine execs from a trio of leading shot makers are looking at distribution hurdles ahead.

News of an FDA plant inspection for a Macrogenics drug boosted investor confidence in BMS' ability to meet its year-end deadline for liso-cel.

BioCryst has scored FDA approval for Orladeyo, the first oral option to prevent hereditary angioedema attacks in patients 12 and older.